GSA CAPITAL PARTNERS LLP

Position in VTGN — Vistagen Therapeutics, Inc.

CIK 1362033 LONDON, X0

Position in VTGN

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$12,554

-$15,855 QoQ

Shares Held

54,584

+9.5% QoQ

Ownership

0.123%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#24

of 48 holders

Holding Since

Sep 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $104,909,103 across 164 Biotechnology names. VTGN ranks #161 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IOVA	Iovance Biotherapeutics, Inc.	655,318	$2,726,122
2	IMVT	Immunovant, Inc.	65,267	$2,514,737
3	GOSS	Gossamer Bio, Inc.	187,337	$2,472,846
4	AXSM	Axsome Therapeutics, Inc.	9,419	$2,305,488
5	CABA	Cabaletta Bio, Inc.	668,563	$2,079,230
6	MLTX	MoonLake Immunotherapeutics	106,695	$2,077,351
7	ATYR	aTYR PHARMA INC	3,454,863	$2,062,553
8	CORT	Corcept Therapeutics Inc	23,257	$2,022,196

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$12,554	54,584	+9.5%	Shares	Sole	2026-08-06
2026-03-31	$28,409	49,842	+58.3%	Shares	Sole	2026-05-08
2025-09-30	$111,775	31,486	-32.7%	Shares	Sole	2025-11-07
2023-09-30	$245,137	46,782	-76.5%	Shares	Sole	2023-11-15
2023-06-30	$371,785	198,816	-84.4%	Shares	Sole	2023-08-14
2023-03-31	$153,025	1,275,215	-75.0%	Shares	Sole	2023-05-12
2022-12-31	$509,535	5,095,354	-2.4%	Shares	Sole	2023-02-13
2022-09-30	$783,343	5,222,292	+3686.0%	Shares	Sole	2022-11-14
2022-06-30	$121,385	137,938	+86.5%	Shares	Sole	2022-08-09
2022-03-31	$91,721	73,969	+131.3%	Shares	Sole	2022-05-11
2021-09-30	$87,636	31,984	—	Shares	Sole	2021-11-12
No filing history on record for this holder in this stock.